Great Point Partners as of Sept. 30, 2025
Portfolio Holdings for Great Point Partners
Great Point Partners holds 30 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals (AMLX) | 9.5 | $23M | 1.7M | 13.59 | |
| Rezolute (RZLT) | 9.5 | $23M | 2.5M | 9.40 | |
| Nektar Therapeutics (NKTR) | 7.0 | $17M | 300k | 56.90 | |
| Zura Bio (ZURA) | 6.8 | $17M | 3.8M | 4.33 | |
| Soleno Therapeutics (SLNO) | 6.3 | $15M | 225k | 67.60 | |
| Ascendis Pharma A S (ASND) | 6.1 | $15M | 75k | 198.81 | |
| Abivax SA F (ABVX) | 5.3 | $13M | 150k | 84.90 | |
| Apogee Therapeutics (APGE) | 5.0 | $12M | 304k | 39.73 | |
| Dianthus Therapeutics (DNTH) | 4.3 | $11M | 266k | 39.35 | |
| Cytokinetics (CYTK) | 3.4 | $8.2M | 150k | 54.96 | |
| Immunovant (IMVT) | 3.3 | $8.1M | 500k | 16.12 | |
| Xenon Pharmaceuticals (XENE) | 3.3 | $8.0M | 200k | 40.15 | |
| Neurogene (NGNE) | 3.2 | $7.7M | 447k | 17.33 | |
| Eupraxia Pharmaceuticals (EPRX) | 2.9 | $7.1M | 1.2M | 5.90 | |
| Upstream Bio (UPB) | 2.3 | $5.6M | 300k | 18.81 | |
| Jade Biosciences (JBIO) | 2.3 | $5.5M | 633k | 8.63 | |
| Ionis Pharmaceuticals (IONS) | 2.2 | $5.2M | 80k | 65.42 | |
| Akero Therapeutics (AKRO) | 2.0 | $4.9M | 104k | 47.48 | |
| Taysha Gene Therapies (TSHA) | 2.0 | $4.9M | 1.5M | 3.27 | |
| Context Therapeutics (CNTX) | 1.9 | $4.5M | 4.7M | 0.97 | |
| Pharvaris N V (PHVS) | 1.6 | $3.9M | 155k | 24.95 | |
| Dbv Technologies Sa (DBVT) | 1.6 | $3.8M | 379k | 10.00 | |
| Legend Biotech 2 Adr Rep Ord (LEGN) | 1.5 | $3.7M | 114k | 32.61 | |
| Oruka Therapeutics (ORKA) | 1.5 | $3.5M | 183k | 19.23 | |
| Unicycive Therapeutics (UNCY) | 1.4 | $3.5M | 797k | 4.36 | |
| Sana Biotechnology (SANA) | 1.0 | $2.5M | 700k | 3.55 | |
| Absci Corp (ABSI) | 1.0 | $2.4M | 796k | 3.04 | |
| Harmony Biosciences Hldgs In Call Option (HRMY) | 1.0 | $2.3M | 85k | 27.56 | |
| Pliant Therapeutics (PLRX) | 0.5 | $1.3M | 850k | 1.48 | |
| Capricor Therapeutics Put Option (CAPR) | 0.3 | $632k | 88k | 7.21 |
